This optimized method consistently yields a high and stable activation percentage, proving valuable for the analysis of IgE-mediated activation in HLMCs and for assessing the impact of drugs targeting HLMCs in the context of lung diseases, such as asthma. This evidence concerns the gene IGHE and asthma.